Background: Current vascular grafts and cardiovascular implants face critical challenges from thrombosis and intimal hyperplasia, largely due to the lack of an adaptive endothelial-like interface that can dynamically respond to hemodynamic forces. While various passive anti-fouling coatings exist, none have successfully integrated real-time, flow-responsive nitric oxide (NO) regulation with endothelial cell mimicry.
Methods: Inspired by the glycocalyx-endothelial interface, we developed a novel zwitterionic sulfobetaine methacrylate (SBMA) hydrogel matrix embedded with shear-stress-sensitive mechanophores (mechano-activated S-nitrosothiol donors). The coating was fabricated via a one-step photopolymerization on 316L stainless steel substrates, with thickness controlled at 45 ± 5 μm. Surface chemistry was characterized by ATR-FTIR and XPS, and NO release kinetics under varying shear stresses (0–30 dyn/cm²) were quantified using an electrochemical NO analyzer.
Results: The biomimetic coating exhibited exceptional anti-fouling properties, reducing platelet adhesion by 98.3% compared to bare metal under static conditions (n=6, p<0.001). Critically, NO release demonstrated precise shear-responsiveness: basal release was 0.23 ± 0.05 pmol/cm²/s under low shear (2 dyn/cm²), which increased significantly to 4.87 ± 0.32 pmol/cm²/s at arterial shear (15 dyn/cm²), closely mimicking the physiological NO production of healthy endothelium (3.5–5.0 pmol/cm²/s). In a rabbit arteriovenous shunt model (n=8), the coated grafts showed no thrombus formation after 4 hours of blood exposure, whereas uncoated controls exhibited 85% occlusion. Furthermore, endothelial cell adhesion and proliferation on the coating increased 4.2-fold over 7 days under flow conditions, indicating a pro-healing interface.
Conclusion: This work presents the first synthetic vascular interface that combines true shear-responsive NO release with endothelial-mimetic anti-fouling properties. The mechano-chemical coupling mechanism provides a new biomimetic strategy for next-generation cardiovascular implants requiring dynamic biological integration.